The European Patent Office has closed a loophole that meant it was theoretically possible to clone human beings in Europe after complaints about a patent granted to the University of Edinburgh and Australian biotech firm Stem Cell Sciences. The patent, covering the changing of mammal cells to create a transgenic animal, did not specifically rule out the use of human material. The patent holders said they had not intended to clone humans.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber?
Please or to read this article.
